Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.
- NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_assertion description "[HER2, MET and FGFR2 oncogenic driver alterations define distinct molecular segments for targeted therapies in gastric carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.
- NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_assertion evidence source_evidence_literature NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.
- NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_assertion SIO_000772 24518603 NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.
- NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_assertion wasDerivedFrom befree-2016 NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.
- NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_assertion wasGeneratedBy ECO_0000203 NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.
- befree-2016 importedOn "2016-02-19" NP1154273.RArlEUZbL2Fuz9xA2iWeeQvm20xCxEUzOvGPCG1TVvXw8130_provenance.